These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 12213672

  • 1. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
    Patócs A, Tóth M, Barta C, Sasvári-Székely M, Varga I, Szücs N, Jakab C, Gláz E, Rácz K.
    Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
    [Abstract] [Full Text] [Related]

  • 2. The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas - hormonal and mutation screening.
    Wagnerova H, Lazúrová I, Habalová V, Dudásová D, Vrzgula A.
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):272-5. PubMed ID: 18589890
    [Abstract] [Full Text] [Related]

  • 3. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne.
    Ostlere LS, Rumsby G, Holownia P, Jacobs HS, Rustin MH, Honour JW.
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):209-15. PubMed ID: 9579234
    [Abstract] [Full Text] [Related]

  • 4. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.
    Bernini GP, Brogi G, Vivaldi MS, Argenio GF, Sgrò M, Moretti A, Salvetti A.
    J Endocrinol Invest; 1996 Dec; 19(11):745-52. PubMed ID: 9061508
    [Abstract] [Full Text] [Related]

  • 5. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
    Bachega TA, Brenlha EM, Billerbeck AE, Marcondes JA, Madureira G, Arnhold IJ, Mendonca BB.
    J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
    [Abstract] [Full Text] [Related]

  • 6. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
    Seppel T, Schlaghecke R.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
    [Abstract] [Full Text] [Related]

  • 7. Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status.
    Dolzan V, Prezelj J, Vidan-Jeras B, Breskvar K.
    Eur J Endocrinol; 1999 Aug; 141(2):132-9. PubMed ID: 10427156
    [Abstract] [Full Text] [Related]

  • 8. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.
    Escobar-Morreale HF, San Millán JL, Smith RR, Sancho J, Witchel SF.
    Fertil Steril; 1999 Oct; 72(4):629-38. PubMed ID: 10521100
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and Clinical Outcome of CYP21A2 Gene Mutations in Patients with Nonfunctional Adrenal Incidentalomas.
    Kiedrowicz B, Binczak-Kuleta A, Lubikowski J, Koziolek M, Andrysiak-Mamos E, Ostanek-Panka M, Ciechanowicz A, Syrenicz A.
    Horm Metab Res; 2015 Aug; 47(9):662-7. PubMed ID: 25970792
    [Abstract] [Full Text] [Related]

  • 10. Limited value of serum steroid measurements in identification of mild form of 21-hydroxylase deficiency.
    Török D, Halász Z, Garami M, Homoki J, Fekete G, Sólyom J.
    Exp Clin Endocrinol Diabetes; 2003 Feb; 111(1):27-32. PubMed ID: 12605347
    [Abstract] [Full Text] [Related]

  • 11. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
    Knochenhauer ES, Cortet-Rudelli C, Cunnigham RD, Conway-Myers BA, Dewailly D, Azziz R.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):479-85. PubMed ID: 9024240
    [Abstract] [Full Text] [Related]

  • 12. No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours.
    Kjellman M, Holst M, Bäckdahl M, Larsson C, Farnebo LO, Wedell A.
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):343-6. PubMed ID: 10435060
    [Abstract] [Full Text] [Related]

  • 13. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
    Admoni O, Israel S, Lavi I, Gur M, Tenenbaum-Rakover Y.
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
    [Abstract] [Full Text] [Related]

  • 14. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
    Dolzan V, Sólyom J, Fekete G, Kovács J, Rakosnikova V, Votava F, Lebl J, Pribilincova Z, Baumgartner-Parzer SM, Riedl S, Waldhauser F, Frisch H, Stopar-Obreza M, Krzisnik C, Battelino T.
    Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
    [Abstract] [Full Text] [Related]

  • 15. Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency.
    Kösel S, Burggraf S, Fingerhut R, Dörr HG, Roscher AA, Olgemöller B.
    Clin Chem; 2005 Feb; 51(2):298-304. PubMed ID: 15608154
    [Abstract] [Full Text] [Related]

  • 16. Increased prevalence of heterozygous 21-OH germline mutations in patients with adrenal incidentalomas.
    Baumgartner-Parzer SM, Pauschenwein S, Waldhäusl W, Pölzler K, Nowotny P, Vierhapper H.
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):811-6. PubMed ID: 12072053
    [Abstract] [Full Text] [Related]

  • 17. Correlation between genotype and hormonal levels in heterozygous mutation carriers and non-carriers of 21-hydroxylase deficiency.
    Napolitano E, Manieri C, Restivo F, Composto E, Lanfranco F, Repici M, Pasini B, Einaudi S, Menegatti E.
    J Endocrinol Invest; 2011 Jun; 34(7):498-501. PubMed ID: 20671415
    [Abstract] [Full Text] [Related]

  • 18. Newborn screening for 21-hydroxylase deficiency: results of CYP21 molecular genetic analysis.
    Witchel SF, Nayak S, Suda-Hartman M, Lee PA.
    J Pediatr; 1997 Aug; 131(2):328-31. PubMed ID: 9290628
    [Abstract] [Full Text] [Related]

  • 19. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.
    Kelestimur F, Everest H, Dundar M, Tanriverdi F, White C, Witchel SF.
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):205-8. PubMed ID: 19085698
    [Abstract] [Full Text] [Related]

  • 20. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia.
    Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, Day DJ.
    J Clin Endocrinol Metab; 1999 Mar; 84(3):960-6. PubMed ID: 10084579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.